🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSemaglutide (Ozempic / Wegovy)Can I drink on sema or will I die — looking for input

Can I drink on sema or will I die — looking for input

Dr.NutriCornell Wed, Jun 4, 2025 at 10:39 PM 30 replies 1,673 viewsPage 1 of 6
This thread is more than 12 months old. Information may be outdated. Consider searching for more recent discussions.
Dr.NutriCornell
Senior Member
1,345
6,234
Mar 2024
Ithaca, NY
Jun 4, 2025 at 10:39 PM#1

I have been on semaglutide for nine months, currently holding 1.7mg rather than pushing to 2.4mg, and the last two dose steps bought me much less than the first two did.

What I am trying to establish is what the dose-response curve actually looks like above 1.7mg, because the trial means hide how few people account for the extra loss.

Happy to be told the question itself is wrong.

2 22emily_PDX, Dr.SleepRoch
Reply Quote Save Share Report
Dr.ObesityMed
VIP Member
3,456
19,234
Nov 2023
Denver, CO
Online
Jun 4, 2025 at 10:57 PM#2

Answering the narrow version, because the broad one does not have a single answer. The dose-response is real but shallow at the top. Across STEP 1 and STEP 4 the gap between 1.7mg and 2.4mg is a couple of percentage points of body weight on average, and the average is carrying a wide spread — plenty of people at 1.7mg sit above the 2.4mg mean. If a dose is working and tolerable, "working" is the relevant variable, not "maximal".

1 21PharmacoVig_BOS
Reply Quote Save Share Report
steve_okc
Member
489
2,123
Jul 2024
Oklahoma City, OK
Jun 4, 2025 at 11:15 PM#3
Dr.ObesityMed said:
The dose-response is real but shallow at the top.

No disagreement with Dr.ObesityMed. One condition attached. Steady state is the thing most people miss. The terminal half-life is about a week, so every dose step takes four to five weeks to fully express itself. Judging a step at day ten is judging the ascent, not the plateau, and it is the single commonest reason people escalate before they needed to.

50 20ZaraB_AL, JakeSmashed95, NauseaFreeNow and 47 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
laura_annarbor
Member
189
890
Dec 2024
Ann Arbor, MI
Jun 4, 2025 at 11:33 PM#4
Dr.NutriCornell said:
I have been on semaglutide for nine months, currently holding 1.7mg rather than pushing to 2.4mg, and the last two dose steps bought me much less than…

All true, with one condition: that curve is for people who reached the dose on schedule. Anyone who slowed the ladder for tolerability is on a different, flatter curve, and comparing yourself with the published mean will make you feel like a non-responder when you are not.

49 19laura_annarbor, JenMemphis, pat_auckland and 46 others
Reply Quote Save Share Report
LibrarianMeg
Senior Member
1,678
7,890
Mar 2024
Baltimore, MD
Jun 5, 2025 at 1:08 AM#5

From the other side of the consultation, briefly.

Dr.NutriCornell said:
...but the FDA says semaglutide...

Interesting point. I want to add some regulatory nuance: the FDA labeling reflects the specific clinical trial data submitted for approval. Real-world clinical practice often extends beyond the FDA label based on emerging evidence and clinical judgment.

Example: semaglutide was first approved for diabetes (Ozempic), then obesity (Wegovy). The molecule didn't change — our understanding of its applications expanded. Similarly, semaglutide may evolve as more data accumulates.

Last edited: Jun 5, 2025 at 3:08 AM
48 18TomFromTexas, mike.trainer_LA, sarah_nash92 and 45 others
Reply Quote Save Share Report
1236

Similar Threads

STEP 1-5 trials comprehensive summary — efficacy endpoints compiled12 replies
Oral semaglutide 50mg Phase 3 — OASIS program results16 replies
Semaglutide pharmacokinetics — half-life, Tmax, steady state modeling10 replies
Compounded semaglutide stability data — temperature and light sensitivity16 replies
0.25mg → 2.4mg titration: optimal schedule based on clinical data6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register